首页> 外文期刊>American Journal of Ophthalmology Case Reports >Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis
【24h】

Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis

机译:环孢素和泼尼松龙联合治疗可作为治疗顽固性乳突脉络膜视网膜炎的潜在策略

获取原文
获取外文期刊封面目录资料

摘要

PurposeRelentless placoid chorioretinitis (RPC) is a new disease concept that was proposed by Jones et al. in 2000. Some cases of RPC have been reported; however, a treatment strategy has not yet been established. We report herein four cases of patients diagnosed with RPC.ObservationsWe experienced four cases of RPC in patients aged 24–51 years. All patients exhibited retinal lesions similar to that seen in acute posterior multifocal placoid pigment epitheliopathy or serpiginous choroiditis from the posterior pole to the surrounding region. Although patients underwent systemic prednisolone (PSL) therapy, recurrence was observed and the retinal scar formation was progressive; they were then diagnosed with RPC. In all cases, cyclosporine (CyA) was administered in addition to PSL, no recurrence was observed thereafter.Conclusions and ImportanceRPC is a rare disease, and a treatment strategy has not yet been established. CyA and PSL combination therapy is considered to be effective in the treatment of RPC.
机译:目的无情的乳突脉络膜视网膜炎(RPC)是Jones等人提出的一种新的疾病概念。在2000年。据报道有一些RPC案例。但是,尚未建立治疗策略。我们在此报告了四例确诊为RPC的患者。观察我们在24-51岁的患者中经历了四例RPC。从后极到周围区域,所有患者均表现出与急性后路多灶性乳突色素上皮病或锯齿状脉络膜炎相似的视网膜病变。尽管患者接受了全身泼尼松龙(PSL)治疗,但观察到复发,并且视网膜瘢痕形成是进行性的。然后他们被诊断出患有RPC。在所有情况下,除PSL之外还使用环孢霉素(CyA),此后未见复发。结论和重要性RPC是一种罕见疾病,尚未建立治疗策略。 CyA和PSL联合疗法被认为对RPC有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号